Biblio
Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium. FASEB J. 2013.
CAVIN1-Mediated hERG Dynamics: A Novel Mechanism Underlying the Interindividual Variability in Drug-Induced Long QT. Circulation. 2024.
CRISPR/CAS9 Gene-Editing Strategies in Cardiovascular Cells. Cardiovasc Res. 2019.
. CRISPRed Cardiomyocytes to Decrypt Variants of Uncertain Significance. J Am Coll Cardiol. 2018;72(1):76-78.
. Generation of iPSC line from MYH7 R403L mutation carrier with severe hypertrophic cardiomyopathy and isogenic CRISPR/Cas9 corrected control. Stem Cell Res. 2021;52:102245.
Small Molecule-Mediated Directed Differentiation of Human Embryonic Stem Cells Toward Ventricular Cardiomyocytes. Stem Cells Transl Med. 2013.
Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: From molecular mechanisms to therapeutic targets. Eur J Heart Fail. 2021.
Towards Precision Medicine With Human iPSCs for Cardiac Channelopathies. Circ Res. 2019;125(6):653-658.
.